Psychedelic Mushrooms Could Be The Solution To Eradicating Anti-Depressant Medication In The Next Five Years


Researchers at the world’s first psychedelic center, Centre of Psychedelic Research at London’s Imperial College said that “magic mushrooms” or otherwise known as psilocybin could completely replace antidepressants that doctors have been prescribing within the next five years.

This opinionated theory is also agreed upon by similar researched released from John Hopkins University, that says victims that have experienced emotional traumas may have a longer term relief when ingesting natural psilocybin fungi, instead of anti-depressant prescribed drugs.

Head of the research center, Dr. Robin Earhart-Harris is conducting one of the very first trials in order to investigate the outcome of therapy involving magic mushrooms – which as of this moment is still illegal in the UK – as compared to the effects of chemical drugs. These trials have resulted in cathartic emotional “release.” This was compared to the usual effects of anti-depressants that provide a dull and “blunted” effect to the patients. This study was the first of many that are planning to be conducted at London’s Imperial College.

In the trial, there were 60 participants that had moderate to severe depression who were given psilocybin treatment. A clinical psychologist also conducted a therapy session with each of them. Some participants will be randomly chosen to receive the fungi, or placebo. The researchers nor the participants will know who receives what in the group.

The effects of the fungi will be compared to the anti-depressant escitalopram, which is a type of selective serotonin reuptake inhibitors (SSRIs). Most of the chemical drugs available in the market is made of this.

Dr. Carhart Harris told the Independent that “if you ask people who are taking SSRIs chronically, they often say ‘I feel blunted’. With psilocybin therapy they say the opposite, they talk about an emotional release, a reconnection, and this key emotional centre being more responsive.” The description for blunted means that both the patient’s positive and negative emotions were suppressed.


Indications seen in MRI studies suggest that the side-effects of the psychedelics on the brain is “twice as long” for escitalopram as compared to psilocybin therapy. The fungi also acts much faster than the anti-depressant, which sometimes takes months to finally take effect.

Dr. Earhart-Harris says that this therapy isn’t made for everybody. There are people with psychosis and regulators that perhaps need more evidence of the safety and effectiveness of this alternative through other clinical trials. Everyone else could be a potential candidate in the future. In fact, the 2018 Global Drug Survey did state that magic mushrooms are the safest recreational drug to be ingested.

“I would imagine if you had some bookmakers doing the odds, there would be strong odds on that [psychedelic therapy] will be licensed sometime in the next five to 10 years – maybe sooner. The implications of that are actually frightening to me, thinking of the power and influence of big p*****. What are they going to do with that if there’s this big public demand for the ‘mushroom therapy’, and not the Prozac?” Dr. Carhart-Harris said.

The anti-depressant drug market is such a lucrative business that in ten years, the demand for the chemical drugs in the U.K. alone has doubled. According the Columbia University’s Milaman School of Public Health, the use of anti-anxiety medication and anti-depressants soared in the United States from 2005 to 2015. By 2023, it is estimated that the anti-depressant drug market will reach $15.98 billion worth, according to Allied Market Research.

If the clinical trials and further research can prove the safety and effectiveness of psilocybin therapy, other cities will most likely follow the lead of Denver, Colorado – a huge move that will definitely rock the boat of Big P*****.

Dr. James Rucker, a fellow researcher at the Institute of Psychiatry, Psychology and Neuroscience in King’s College London who has been studying the benefits of psychedelics said that there is a “possibility” that fungi could possibly be prescribed instead of anti-anxiety medication within the next five years. “But only if everything goes to plan, and you know what they say about best-laid plans. Like all treatments, they will suit some people but not others. The trick, as ever, is trying to work that out before administration. But that trick has proven to be remarkably difficult to pull off, particularly in psychiatry,” he added.

What are your thoughts? Please comment below and share this news!

True Activist / Report a typo

Popular on True Activist